Business Description
![Legend Biotech Corp Legend Biotech Corp logo](https://static.gurufocus.com/logos/0C0000BUGQ.png?14)
Legend Biotech Corp
NAICS : 541714
SIC : 2834
ISIN : US52490G1022
Share Class Description:
LEGN: ADRDescription
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.89 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | -0.79 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 9.52 | |||||
Beneish M-Score | -1.58 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 36.6 | |||||
3-Year EBITDA Growth Rate | -2.5 | |||||
3-Year EPS without NRI Growth Rate | -2.8 | |||||
3-Year FCF Growth Rate | -3.3 | |||||
3-Year Book Growth Rate | 15.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 81.92 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 76.26 | |||||
9-Day RSI | 78.99 | |||||
14-Day RSI | 75.83 | |||||
6-1 Month Momentum % | -20.62 | |||||
12-1 Month Momentum % | -40.23 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.66 | |||||
Quick Ratio | 5.57 | |||||
Cash Ratio | 5.22 | |||||
Days Inventory | 38.87 | |||||
Days Sales Outstanding | 25.23 | |||||
Days Payable | 57.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11 | |||||
Shareholder Yield % | -0.56 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.35 | |||||
Operating Margin % | -126.35 | |||||
Net Margin % | -135.92 | |||||
FCF Margin % | -76.79 | |||||
ROE % | -40.06 | |||||
ROA % | -27.08 | |||||
ROIC % | -117.38 | |||||
ROC (Joel Greenblatt) % | -236.19 | |||||
ROCE % | -29.63 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 31.49 | |||||
PB Ratio | 8.86 | |||||
Price-to-Tangible-Book | 10.37 | |||||
EV-to-EBIT | -22.01 | |||||
EV-to-Forward-EBIT | -29.97 | |||||
EV-to-EBITDA | -23.1 | |||||
EV-to-Forward-EBITDA | -30.87 | |||||
EV-to-Revenue | 28.62 | |||||
EV-to-Forward-Revenue | 18.11 | |||||
EV-to-FCF | -37.28 | |||||
Price-to-Net-Current-Asset-Value | 12.87 | |||||
Price-to-Net-Cash | 14.94 | |||||
Earnings Yield (Greenblatt) % | -4.54 | |||||
FCF Yield % | -2.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LEGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Legend Biotech Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 342.798 | ||
EPS (TTM) ($) | -2.58 | ||
Beta | -0.05 | ||
Volatility % | 39.01 | ||
14-Day RSI | 75.83 | ||
14-Day ATR ($) | 2.50511 | ||
20-Day SMA ($) | 51.8485 | ||
12-1 Month Momentum % | -40.23 | ||
52-Week Range ($) | 38.6 - 77.3 | ||
Shares Outstanding (Mil) | 182.28 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Legend Biotech Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Legend Biotech Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Legend Biotech Corp Frequently Asked Questions
What is Legend Biotech Corp(LEGN)'s stock price today?
The current price of LEGN is $56.62. The 52 week high of LEGN is $77.30 and 52 week low is $38.60.
When is next earnings date of Legend Biotech Corp(LEGN)?
The next earnings date of Legend Biotech Corp(LEGN) is 2024-08-09.
Does Legend Biotech Corp(LEGN) pay dividends? If so, how much?
Legend Biotech Corp(LEGN) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |